RRC ID 18217
著者 Wang F, Fang W, Zhang MR, Zhao M, Liu B, Wang Z, Hua Z, Yang M, Kumata K, Hatori A, Yamasaki T, Yanamoto K, Suzuki K.
タイトル Evaluation of chemotherapy response in VX2 rabbit lung cancer with 18F-labeled C2A domain of synaptotagmin I.
ジャーナル J Nucl Med
Abstract UNLABELLED:The C2A domain of synaptotagmin I can target apoptotic cells by binding to exposed anionic phospholipids. The goal of this study was to synthesize and develop (18)F-labeled C2A-glutathione-S-transferase (GST) as a molecular imaging probe for the detection of apoptosis and to assess the response of paclitaxel chemotherapy in VX2 rabbit lung cancer.
METHODS:(18)F-C2A-GST was prepared by labeling C2A-GST with N-succinimidyl 4-(18)F-fluorobenzoate ((18)F-SFB). (18)F-C2A-GST was confirmed by high-performance liquid chromatography and sodium dodecyl sulfate polyacrylamide gel electrophoresis. The binding of (18)F-C2A-GST toward apoptosis was validated in vitro using camptothecin-induced Jurkat cells. Biodistribution of (18)F-C2A-GST was determined in mice by a dissection method and small-animal PET. Single-dose paclitaxel was used to induce apoptosis in rabbits bearing VX2 tumors (n = 6), and 2 VX2 rabbits without treatment served as control. (18)F-C2A-GST PET was performed before and at 72 h after therapy, and (18)F-FDG PET/CT was also performed before treatment. To confirm the presence of apoptosis, tumor tissue was analyzed and activated caspase-3 was measured.
RESULTS:(18)F-C2A-GST was obtained with more than 95% radiochemical purity and was stable for 4 h after formulation. (18)F-C2A-GST bound apoptotic cells specifically. Biodistribution in mice showed that (18)F-C2A-GST mainly excreted from the kidneys and rapidly cleared from blood and nonspecific organs. High focal uptake of (18)F-C2A-GST in the tumor area was determined after therapy, whereas no significant uptake before therapy was found in the tumor with (18)F-FDG-avid foci. The maximum standardized uptake value after therapy was 0.47 ± 0.28, significantly higher than that in the control (0.009 ± 0.001; P < 0.001). The apoptotic index was 79.81% ± 8.73% in the therapy group, significantly higher than that in the control (5.03% ± 0.81%; P < 0.001). Activated caspase-3 after paclitaxel treatment increased to 69.55% ± 16.27% and was significantly higher than that in the control (12.26% ± 5.39%; P < 0.001).
CONCLUSION:(18)F-C2A-GST was easily synthesized by conjugation with (18)F-SFB and manifested a favorable biodistribution. Our results demonstrated the feasibility of (18)F-C2A-GST for the early detection of apoptosis after chemotherapy in a VX2 lung cancer model that could imitate the human lung cancer initiation, development, and progress.
巻・号 52(4)
ページ 592-9
公開日 2011-4-1
DOI 10.2967/jnumed.110.081588
PII jnumed.110.081588
PMID 21421722
PMC PMC3866918
MeSH Animals Antineoplastic Agents, Phytogenic / therapeutic use Apoptosis / drug effects Caspase 3 / metabolism Chromatography, High Pressure Liquid Electrophoresis, Polyacrylamide Gel Feasibility Studies Fluorine Radioisotopes Humans Image Processing, Computer-Assisted Indicators and Reagents Isotope Labeling / methods Jurkat Cells Lung Neoplasms / diagnostic imaging* Lung Neoplasms / drug therapy* Male Mice Molecular Imaging Paclitaxel / therapeutic use Positron-Emission Tomography Rabbits Radiopharmaceuticals* / chemistry Radiopharmaceuticals* / pharmacokinetics Synaptotagmin I* / chemistry Synaptotagmin I* / pharmacokinetics Tissue Distribution
IF 7.887
引用数 23
WOS 分野 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
リソース情報
ヒト・動物細胞 Jurkat(RCB0806)